Table IV.
List of various marketed nanoformulations
| Nanoformulation | Active constituents | Therapeutic use | Name of company |
|---|---|---|---|
| Silicon-coated iron oxide | Ferumoxsil | Imaging contrast agents | AMAG Pharmaceuticals |
| Nanocrystal particles | Aprepitant | Antiemetic | Merck |
| Phosphate-binding polymer | Sevelamer | Renal failure | Genzyme (Daiichi licensed) |
| Nanocrystal particles | Sirolimus | Immunosuppressive | Pfizer/Wyeth |
| Nanocrystal particles | Fenofibrate | Hypercholesterolemia | ScielePharma |
| Cholesterol-binding polymer | Welchol | Type 2 diabetes | Genzyme |
| Nanocrystal particles | Megestrol | Antianoretic | Par Pharmaceuticals |